Molecular diagnosis and genetic counseling for fragile X mental retardation

Neurology India

Volumn 52, Issue 1, 2004, Pages 36-42

  Pandey, U B ^a   Phadke, S R ^a   Mittal, B ^a  

^a SANJAY GANDHI POSTGRADUATE INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Fragile X mental retardation; Genetic counseling; Mutation; Premutation

Indexed keywords

DNA; FRAGILE X MENTAL RETARDATION PROTEIN; MESSENGER RNA; FMR1 PROTEIN, HUMAN; NERVE PROTEIN; RNA BINDING PROTEIN;

CHROMOSOME XQ; CLINICAL FEATURE; CPG ISLAND; DIAGNOSTIC PROCEDURE; DISEASE SEVERITY; FRAGILE X SYNDROME; GENE MUTATION; GENETIC COUNSELING; GENETIC SCREENING; HETEROZYGOTE DETECTION; HUMAN; KARYOTYPE; POLYMERASE CHAIN REACTION; PRENATAL DIAGNOSIS; REVIEW; SOUTHERN BLOTTING; TRINUCLEOTIDE REPEAT; ANIMAL; FEMALE; GENETICS; MALE; MENTAL DEFICIENCY; NUCLEOTIDE REPEAT; PATHOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANIMALS; FEMALE; FRAGILE X MENTAL RETARDATION PROTEIN; FRAGILE X SYNDROME; GENETIC COUNSELING; HUMANS; MALE; MENTAL RETARDATION; NERVE TISSUE PROTEINS; REPETITIVE SEQUENCES, NUCLEIC ACID; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA-BINDING PROTEINS;

EID: 16544377383     PISSN: 00283886     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (75)

1. Fu YH, Kuhl DP, Pizzuti A, Pieretti M, Sutcliffe JS, Richards S, et al. Variation of the CGG repeat at the fragile X site results in genetic instability: resolution of the Sherman paradox. Cell 1991;67:1047-58.
2. Rousseau F. The fragile X syndrome: implications of molecular genetics for the clinical syndrome Eur J Clin Invest 1994;24:1-10.
3. Martin JB, Bell J. A pedigree of mental defect showing sex-linkage. J Neurol Psychiatr 1943;6:154-7.
4. Penrose LS. A clinical and genetic study of 1280 cases of mental defect: special report series No. 229. London: Medical Research Council; 1938.
5. Losowsky MS. Hereditary mental defect showing the pattern of sex influence. J Ment Defic Res 1961;5:60-2.
6. Renpenning H, Gerrard JW, Zaleski WA, Tabata T. Familial sex-linked mental retardation. Canad. Med Ass J 1962;87:954-6.
7. Dunn HG, Renpenning H, Gerrard JW. Mental retardation as a sex-linked defect. Am J Ment. Defic 1963;67:827-48.
8. Lubs HA. A marker X chromosome. Am J Hum Genet 1969;21:231-44.
9. Sutherland GR. Fragile sites on human chromosomes: demonstration of their dependence on the type of tissue culture medium. Science 1977;197:265-6.
10. Turner G, Turner B. X-linked mental retardation. J Med Genet 1974;11:109-13.
11. Jacobs PA, Glover TW, Mayer M, Fox P, Gerrard JW, Dunn HG, et al. X-linked mental retardation: a study of 7 families. Am J Med Genet 1980;7:471-89.
12. Jennings M, Hall JG, Hoehn H. Significance of phenotypic and chromosomal abnormalities in X-linked mental retardation (Martin-Bell or Renpenning syndrome). Am J Med Genet 1980;7:417-32.
13. Martin RH, Lin CC, Mathies BJ, Lowry RB. X-linked mental retardation with macro-orchidism and marker-X chromosomes. Am J Med Genet 1980;7:433-41.
14. Richards BW, Sylvester PE, Brooker C. Fragile X-linked mental retardation: the Martin-Bell syndrome. J Ment Defic Res 1981;25:253-6.
15. Lachiewicz AM, Dawson VV, Spiridigliozzi UA. Physical characteristics of young boys with fragile X syndrome: reasons for difficulties in making a diagnosis in young males. Am J Med Genet 2000;92:229-36.
16. Pennington BF, O'Connor RA, Sudhalter V. Towards a neuropsychology of fragile X syndrome. In: Hagerman R.J. and Silverman A.C editors. Fragile X syndrome: diagnosis, treatment and research. The Johns Hopkins University Press Ltd, London 1991. pp. 173-201.
17. Curfs LM, Wiegers AM, Fryns JP. Intelligence and the fra (X) syndrome: a review. Genet Couns 1991;2:55-62.
18. Oostra BA, Willemsen R. The X chromosome and fragile X mental retardation. Cytogenet Genome Res 2002;99:257-64.
19. Rousseau F, Heitz D, Oberle I, Mandel JL. Selection in blood cells from female carriers of the fragile X syndrome: inverse correlation between age and proportion of active X chromosomes carrying the full mutation. J Med Genet 1991;8:830-6.
20. de Vries BB, Wiegers AM, Smits AP, Mohkamsing S, Duivenvoorden HJ, Fryns JP, et al. Mental status of females with an FMR1 gene full mutation. Am J Hum Genet 1996;58:1025-32.
21. Brown WT, Jenkins EC, Friedman E, Brooks J, Wisniewski K, Raguthu S, et al. Autism is associated with the fragile-X syndrome. J Autism Dev Disord 1982;12:303-8.
22. Hagerman RJ, Jackson AW, Levitas A, Rimland B, Braden M. An analysis of autism in fifty males with the fragile X syndrome. Am J Med Genet 1986;23:359-74.
23. Reiss AL, Feinstein C, Toomey KE, Goldsmith B, Rosenbaum K, Caruso MA. Psychiatric disability associated with the fragile X chromosome. Am J Med Genet 1986;23:393-401.
24. Hagerman RJ, Sobesky WE. Psychopathology in fragile X syndrome. Am J Orthopsychiatry 1989;59:142-52.
25. Hagerman RJ. Physical and behavioral phenotype. In: Hagerman RJ, Silverman MS, editors. Fragile X syndrome. Diagnosis treatment and research. London: Johns Hopkins Press Ltd; 1991. pp. 3-68
26. Reiss AL, Freund L. Behavioral phenotype of fragile X syndrome: DSM-III-R autistic behavior in male children. Am J Med Genet 1992;43:35-46.
27. Hagerman RJ, Silverman AC. Fragile X syndrome: Diagnosis, treatment and research. Baltimore: Johns Hopkins Press Ltd; 1991.
28. Hagerman RJ, Amiri K, Cronister A. Fragile X checklist. Am J Med Genet 1991;38:283-7.
29. Fryns JP, van den Berghe H. Transmission of fragile (X)(827) from normal male(s). Hum Genet 1982;61:262-3.
30. Nielsen KB, Tommerup N, Poulsen H, Mikkelsen M. X-linked mental retardation with fragile X. A pedigree showing transmission by apparently unaffected males and partial expression in female carriers. Hum Genet 1981;59:23-5.
31. Sherman SL, Morton NE, Jacobs PA, Turner G. The marker (X) syndrome: a cytogenetic and genetic analysis. Ann Hum Genet 1984;48:21-37.
32. Sherman SL, Jacobs P, Morton N, Froster-Iskenius U, Howard-Peebles P, Nielsen K, et al. Further segregation analysis of the fragile X syndrome with special reference to transmitting males. Hum Genet 1985;69:289-99.
33. Oberlé I, Heilig R, Moisan J, Kloepher C, Mattei M, Mattei J, et al. Genetic analysis of the fragile-X mental retardation syndrome with two flanking polymorphic DNA-markers. Proc Natl Acad Sci USA 1986;83:1016-20.
34. Verkerk AJ, Pieretti M, Sutcliffe JS, Fu YH, Kuhl DP, Pizzuti A, et al. Identification of a gene (FMR-1) containing a CGG repeat coincident with a breakpoint cluster region exhibiting length variation in fragile X syndrome. Cell 1991;65:905-14.
35. Hagerman RJ, Hagerman PJ. The fragile X premutation: into the phenotypic fold. Curr Opin Genet Dev 2002;12:278-83
36. Heitz D, Devys D, Imbert G, Kretz C, Mandel JL. Inheritance of the fragile X syndrome: size of the fragile X premutation is a major determinant of the transition to full mutation. J Med Genet 1992;29:794-801.
37. Johnston C, Eliez S, Dyer-Friedman J, Hessl D, Glaser B, Blasey C, et al. Neurobehavioral phenotype in carriers of the fragile X premutation. Am J Med Genet 2001;103:314-9.
38. Hagerman PJ, Greco CM, Hagerman RJ. A cerebellar tremor/ ataxia syndrome among fragile X premutation carriers. Cytogenet Genome Res 2003;100:206-12
39. Tassone F, Hagerman RJ, Chamberlain WD, Hagerman PJ. Transcription of the FMR1 gene in individuals with fragile X syndrome. Am J Med Genet 2000;97:195-203.
40. Mila M, Castellvi-Bel S, Sanchez A, Barcelo A, Badenas C, Mallolas J, et al. Rare variants in the promoter of the fragile X syndrome gene (FMR1). Mol Cell Probes 2000;14:115-9.
41. Gedeon AK, Baker E, Robinson H, Partington MW, Gross B, Manca A, et al. Fragile X syndrome without CCG amplification has an FMRI deletion. Nat Genet 1992;1:341-4.
42. Wohrle D, Kotzot D, Hirst MC, Manca A, Korn B, Schmidt A, et al. A microdeletion of less than 250 kb, including the proximal part of the FMR-1 gene and the fragile-X site, in a male with the clinical phenotype of fragile-X syndrome. Am J Hum Genet 1992;51:299-306.
43. Tarleton J, Richie R, Schwartz C, Rao K, Aylsworth AS, Lachiewicz A. An extensive de novo deletion removing FMRI in a patient with mental retardation and the fragile X syndrome phenotype. Hum Mol Genet 1993;2:1973-4.
44. Gu Y, Lugenbeel KA, Vockley JG, Grody WW, Nelson DL. A de novo deletion in FMRI in a patient with developmental delay. Hum Mol Genet 1994;3:1705-6.
45. Quan F, Grompe M, Jakobs P, Popovich BW. Spontaneous deletion in the FMRI gene in a patient with fragile X syndrome and cherubism. Hum Mol Genet 1995;4:1681-4.
46. Quan F, Zonana J, Gunter K, Peterson KL, Magenis RE, Popovich BW. An atypical case of fragile X syndrome caused by a deletion that includes the FMRI gene. Am J Hum Genet 1995;56:1042-51.
47. Kunst CB, Zerylnick C, Karickhoff L, Eichler E, Bullard J, Chalifoux M, et al. FMR1 in global populations. Am J Hum Genet 1996;58:513-22.
48. Nolin SL, Lewis FA, Ye LL, Houck GE, Glicksman AE, Limprasert P, et al. Familial transmission of the FMR1 CGG repeat.Am J Hum Genet 1996;59:1252-61.
49. Chiurazzi P, Macpherson J, Sherman S, Neri G. Significance of linkage disequilibrium between the fragile X locus and its flanking markers. Am J Med Genet 1996;64:203-8.
50. Haataja R, Vaisanen ML, Li M, Ryynanen M, Leisti J. The fragile X syndrome in Finland: demonstration of a founder effect by analysis of microsatellite haplotypes. Hum Genet 1994;94:479-83.
51. Devys D, Lutz Y, Rouyer N, Bellocq JP, Mandel JL. The FMR-1 protein is cytoplasmic, most abundant in neurons and appears normal in carriers of a fragile X premutation. Nat Genet 1993;4:335-40.
52. Mittal B, Pandey UB. New insights into the function of fragile X mental retardation protein. Hotspot. Clin Genet 2002;62:191-5.
53. Crawford DC, Acuna JM, Sherman SL. FMRI and the fragile X syndrome: human genome epidemiology review. Genet Med 2001;3:359-71.
54. Sharma D, Gupta M, Thelma BK. Expansion mutation frequency and CGG/GCC repeat polymorphism in FMR1 and FMR2 genes in an Indian population. Genet Epidemiol 2001;20:129-44.
55. Saha S, Karmakar P, Chatterjee C, Banerjee D, Das S, Dasgupta UB. Fragile X syndrome in Calcutta, India. Ann Clin Biochem 2001;38:264-71.
56. Pandey UB, Phadke S, Mittel B. Molecular screening of FRAXA and FRAXE in Indian patients with unexplained mental retardation. Genet Test 2002;6:335-9
57. Jain U, Verma IC, Kapoor AK. Prevalence of fragile X(A) syndrome in mentally retarded children at a genetics referral centre in Delhi, India. Ind J Med Res 1998;108:12-6.
58. Turner G, Robinson H, Laing S, Purvis-Smith S. Preventive screening for the fragile X syndrome. N Engl J Med 1986;315:607-9.
59. Webb TP, Bundey SE, Thake AI, Todd J. Population incidence and segregation ratios in the Martin-Bell syndrome. Am J Med Genet 1986;23:573-80
60. Kahkonen M, Alitalo T, Airaksinen E, Matilainen R, Launiala K, Autio S, et al. Prevalence of the fragile X syndrome in four birth cohorts of children of school age. Hum Genet 1987;77:85-7.
61. Turner G, Robinson H, Ling S, van der Berk M, Colley A, Goddard A, et al. Population screening for fragile X. Lancet 1992;339;1210-3.
62. Jacobs PA, Mayer M, Matsuura J, Rhoads F, Yee SC. A cytogenetic study of a population of mentally retarded males with special reference to the marker (X) syndrome. Hum Genet. 1983;63:139-48.
63. Li SY, Tsai CC, Chou MY, Lin JK. A cytogenetic study of mentally retarded school children in Taiwan with special reference to the fragile X chromosome. Hum Genet 1988;79:292-6.
64. Jacobs PA, Bullman H, Macpherson J, Youings S, Rooney V, Watson A, et al. Population studies of the fragile X: a molecular approach. J Med Genet 1993;30:454-9.
65. Perroni L, Grasso M, Argusti A, Lo Nigro C, Croci GF, Zelante L, et al. Molecular and cytogenetic analysis of the fragile X syndrome in a series of 453 mentally retarded subjects: a study of 87 families. Am J Med Genet 1996;64:176-80.
66. van den Ouweland AM, de Vries BB, Bakker PL, Deelen WH, de Graaff E, et al. DNA diagnosis of the fragile X syndrome in a series of 236 mentally retarded subjects and evidence for reversal of mutation in the FMR-1 gene Am J Med Genet 1994;51:482-5.
67. Hofstee Y, Arinami T, Hamaguchi H. Comparision between the Cytogenetic test for fragile X and the molecular analysis in Japanese mentally retarded individuals Am J Med Genet. 1994:51;466-70.
68. Nanba E, Kohno Y, Matsuda A, Yano M, Sato C, Hashimoto K, et al. Non-radioactive DNA diagnosis for the fragile X syndrome in mentally retarded Japanese males. Brain Devel 1995;17:317-21.
69. Pang CP, Poon PM, Chen QL, Lai KY, Yin CH, Zhao Z, et al. Trinucleotide CGG repeat in the FMRI gene in Chinese mentally retarded patients. Am J Med Genet 1999;84:179-83.
70. Willemsen R, Mohkamsing S, de Vries B, Devys D, van den Ouweland A, Mandel JL, et al. Rapid antibody test for fragile X syndrome. Lancet 1995;345:1147-8.
71. Oostra BA, Jacky PB, Brown WT, Rousseau F. Guidelines for the diagnosis of fragile X syndrome. National Fragile X Foundation. J Med Genet 1993;30:410-3.
72. Warren ST, Nelson DL. Advances in molecular analysis of fragile X syndrome. JAMA 1994;271:536-42.
73. Nolin SL, Brown WT, Glicksman A, Houck GE, Gargano AD, Sullivan A, Biancalana V, et al. Expansion of the fragile X CGG repeat in females with premutation or intermediate alleles. Am J Hum Genet 2003;72:454-64.
74. McConkie-Rosell A, Robinson H, Wake S, Staley LW, Heller K, Cronister A. Dissemination of genetic risk information to relatives in the fragile X syndrome: guidelines for genetic counselors Am J Med Genet 1995;59;426-30.
75. Ryynanen M, Heinonen S, Makkonen M, Kajanoja E, Mannermaa A, Pertti K. Feasibility and acceptance of screening for fragile X mutations in low-risk pregnancies. Eur J Hum Genet 1999;7:212-6.